NIH nhlbi lab researcher DR. Denis sviridov requires synthesis of triglycerides lowering peptides in order to triglycerides lowering peptides to be tested as a treatment of hypertriglyceridemia.
Ended Purchase Order Awarded
- Contract number
- 75N92022P00066
- Awardee
-
Wuxi Apptec (Hongkong) LIMITED UEI JKRKL5UBGYY5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,300
Award facts
- Contract value 100% obligated
- $3,300.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Hong Kong International Airport, 1 Sky Plaza Rd, Chek Lap Kok, Hong Kong
Award details come from SAM.gov/FPDS.
About this award
The National Heart Lung and Blood Institute awarded a purchase order to Wuxi Apptec (Hongkong) LIMITED for $3,300.00 on January 18, 2022, for synthesis of triglycerides-lowering peptides to be tested as a treatment for hypertriglyceridemia. Performance is at Hong Kong International Airport. The order is firm fixed price with an ultimate completion date of February 18, 2022.
Quick answers
Who was awarded contract 75N92022P00066?
75N92022P00066 was awarded to Wuxi Apptec (Hongkong) LIMITED by National Heart Lung and Blood Institute (National Institutes of Health) on January 18, 2022.
How much is contract 75N92022P00066 worth?
The government has obligated $3,300 on 75N92022P00066.
Was contract 75N92022P00066 competed?
The extent of competition for 75N92022P00066 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award